Cargando…
Developing Infectious Disease Strategies for the Developing World
This chapter discusses various drugs for human influenza A (H5N1) and multidrug-resistant mycobacterium tuberculosis (MDR-TB). The H5N1 avian influenza does not presently meet the criteria of an antigenically shifted strain. It is presently an avian strain that has not undergone reassortment with a...
Autores principales: | Lee, Paul J., Krilov, Leonard R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112340/ https://www.ncbi.nlm.nih.gov/pubmed/32287466 http://dx.doi.org/10.1016/S0065-7743(06)41018-6 |
Ejemplares similares
-
Technology innovation for infectious diseases in the developing world
por: So, Anthony D, et al.
Publicado: (2012) -
A trio of infectious diseases and pulmonary embolism: A developing world’s reality
por: Pillay, Somasundram, et al.
Publicado: (2021) -
Current State of Respiratory Syncytial Virus Disease and Management
por: Chatterjee, Archana, et al.
Publicado: (2021) -
RSV Disease: Current Management and the Future of Treatment and Prevention
por: Krilov, Leonard R., et al.
Publicado: (2021) -
Respiratory syncytial virus hospitalizations in US preterm infants after the 2014 change in immunoprophylaxis guidance by the American Academy of Pediatrics
por: Krilov, Leonard R., et al.
Publicado: (2020)